Stereotaxis, Inc.
For the period ended Dec 31, 2024. Filed Mar 14, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 14, 2025
STXS$1.03-9.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets at December 31, 2024 and 2023
| (in thousands, except share amounts) | December 31, 2024 | December 31, 2023 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $12,217 | $19,818 |
| Restricted cash - current | 219 | 525 |
| Accounts receivable, net of allowance of $582 and $672 at 2024 and 2023, respectively | 3,824 | 3,822 |
| Inventories, net | 8,331 | 8,426 |
| Prepaid expenses and other current assets | 1,848 | 676 |
| Total current assets | 26,439 | 33,267 |
| Property and equipment, net | 3,573 | 3,304 |
| Goodwill | 3,764 | - |
| Intangible assets | 7,358 | - |
| Restricted cash | - | 219 |
| Operating lease right-of-use assets | 5,483 | 4,982 |
| Prepaid and other non-current assets | 107 | 137 |
| Total assets | $46,724 | $41,909 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $5,668 | $3,190 |
| Accrued liabilities | 2,922 | 2,972 |
| Deferred revenue | 6,804 | 6,657 |
| Current contingent consideration | 5,638 | - |
| Current portion of operating lease liabilities | 570 | 428 |
| Total current liabilities | 21,602 | 13,247 |
| Long-term deferred revenue | 2,064 | 1,637 |
| Long term contingent consideration | 6,126 | - |
| Operating lease liabilities | 5,436 | 5,062 |
| Other liabilities | 64 | 43 |
| Total liabilities | 35,292 | 19,989 |
| Series A - Convertible preferred stock: | ||
| Convertible preferred stock, Series A, par value $0.001; 10,000,000 shares authorized; | ||
| 21,458 and 22,358 shares outstanding at 2024 and 2023, respectively | 5,352 | 5,577 |
| Stockholders’ equity: | ||
| Common stock, par value $0.001; 300,000,000 shares authorized, | ||
| 85,326,557 and 80,949,697 shares issued at 2024 and 2023, respectively | 85 | 81 |
| Additional paid in capital | 567,926 | 554,148 |
| Treasury stock, 4,015 shares at 2024 and 2023 | (206) | (206) |
| Accumulated deficit | (561,725) | (537,680) |
| Total stockholders’ equity | 6,080 | 16,343 |
| Total liabilities and stockholders’ equity | $46,724 | $41,909 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.